|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gervaz P, Bucher P and Morel P: Two
colons-two cancers: Paradigm shift and clinical implications. J
Surg Oncol. 88:261–266. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mik M, Berut M, Dziki L, Trzcinski R and
Dziki A: Right- and left-sided colon cancer - clinical and
pathological differences of the disease entity in one organ. Arch
Med Sci. 13:157–162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Trosko JE and Lenz HJ: What roles do colon
stem cells and gap junctions play in the left and right location of
origin of colorectal cancers? J Cell Commun Signal. 11:79–87. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jess P, Hansen IO, Gamborg M and Jess T;
Danish Colorectal Cancer Group: A nationwide Danish cohort study
challenging the categorisation into right-sided and left-sided
colon cancer. BMJ Open. 3:e0026082013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benedix F, Schmidt U, Mroczkowski P,
Gastinger I, Lippert H and Kube R; Study Group 'Colon/Rectum
Carcinoma (Primary Tumor)': Colon carcinoma - classification into
right and left sided cancer or according to colonic subsite? -
Analysis of 29,568 patients. Eur J Surg Oncol. 37:134–139. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yahagi M, Okabayashi K, Hasegawa H,
Tsuruta M and Kitagawa Y: The worse prognosis of right-sided
compared with left-sided colon cancers: A systematic review and
meta-analysis. J Gastrointest Surg. 20:648–655. 2016. View Article : Google Scholar
|
|
9
|
Wong HL, Lee B, Field K, Lomax A, Tacey M,
Shapiro J, McKendrick J, Zimet A, Yip D, Nott L, et al: Impact of
primary tumor site on bevacizumab efficacy in metastatic colorectal
cancer. Clin Colorectal Cancer. 15:e9–e15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bae JM, Kim JH and Kang GH: Molecular
subtypes of colorectal cancer and their clinicopathologic features,
with an emphasis on the serrated neoplasia pathway. Arch Pathol Lab
Med. 140:406–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamauchi M, Morikawa T, Kuchiba A, Imamura
Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower
C, et al: Assessment of colorectal cancer molecular features along
bowel subsites challenges the conception of distinct dichotomy of
proximal versus distal colorectum. Gut. 61:847–854. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
13
|
Zhang Z: Propensity score method: A
non-parametric technique to reduce model dependence. Ann Transl
Med. 5:72017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Network NCC: (NCCN)Clinical Practice
Guidelines in Oncology. Colon Cancer, Version 2. 2017, https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
Accessed March 13, 2017.
|
|
15
|
Messersmith WA: Systemic management of
colorectal cancer. J Natl Compr Canc Netw. 15(5S): 699–702. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thompson JS: Core Textbook of Anatomy. 1st
edition. Lippincott Williams & Wilkins; Riverwoods, IL:
1977
|
|
17
|
Guarner F and Malagelada JR: Gut flora in
health and disease. Lancet. 361:512–519. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dabareiner RM and White NA II: Diseases
and surgery of the cecum. Vet Clin North Am Equine Pract.
13:303–315. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ruoff C, Hanna L, Zhi W, Shahzad G,
Gotlieb V and Saif MW: Cancers of the appendix: Review of the
literatures. ISRN Oncol. 2011:7285792011.PubMed/NCBI
|
|
20
|
Price TJ, Beeke C, Ullah S, Padbury R,
Maddern G, Roder D, Townsend AR, Moore J, Roy A, Tomita Y, et al:
Does the primary site of colorectal cancer impact outcomes for
patients with metastatic disease? Cancer. 121:830–835. 2015.
View Article : Google Scholar
|
|
21
|
Loupakis F, Yang D, Yau L, Feng S,
Cremolini C, Zhang W, Maus MK, Antoniotti C, Langer C, Scherer SJ,
et al: Primary tumor location as a prognostic factor in metastatic
colorectal cancer. J Natl Cancer Inst. 107:dju4272015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He WZ, Liao FX, Jiang C, Kong PF, Yin CX,
Yang Q, Qiu HJ, Zhang B and Xia LP: Primary tumor location as a
predictive factor for first-line bevacizumab effectiveness in
metastatic colorectal cancer patients. J Cancer. 8:388–394. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tejpar S, Stintzing S, Ciardiello F,
Tabernero J, Van Cutsem E, Beier F, Esser R, Lenz HJ and Heinemann
V: Prognostic and predictive relevance of primary tumor location in
patients with RAS wild-type metastatic colorectal cancer:
Retrospective analyses of the CRYSTAL and FIRE-3 trials. JAMA
Oncol. Oct 10–2016.Epub ahead of print. PubMed/NCBI
|
|
24
|
Timmcke AE: The ASCRS Textbook of Colon
and Rectal Surgery. Ochsner J. 7:482007.
|
|
25
|
Tsai CE, Wu KL, Chiu YC, Chuah SK, Tai WC,
Hu ML and Liang CM: The incidence and clinical associated factors
of interval colorectal cancers in Southern Taiwan. J Formos Med
Assoc. 117:185–190. 2018. View Article : Google Scholar
|
|
26
|
Parsons HM, Tuttle TM, Kuntz KM, Begun JW,
McGovern PM and Virnig BA: Association between lymph node
evaluation for colon cancer and node positivity over the past 20
years. JAMA. 306:1089–1097. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan X, Chen W, Liu Z, Jiang Z, Hu H, Zhao
Z, Wang S, Chen Y, Wang G and Wang X: Whether regional lymph nodes
evaluation should be equally required for both right and left colon
cancer. Oncotarget. 7:59945–59956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen H, Yang J, Huang Q, Jiang MJ, Tan YN,
Fu JF, Zhu LZ, Fang XF and Yuan Y: Different treatment strategies
and molecular features between right-sided and left-sided colon
cancers. World J Gastroenterol. 21:6470–6478. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
O'Connor ES, Greenblatt DY, LoConte NK,
Gangnon RE, Liou JI, Heise CP and Smith MA: Adjuvant chemotherapy
for stage II colon cancer with poor prognostic features. J Clin
Oncol. 29:3381–3388. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guan X, Chen W, Jiang Z, Liu Z, Miao D, Hu
H, Zhao Z, Yang R and Wang X: Exploration of the optimal minimum
lymph node count after colon cancer resection for patients aged 80
years and older. Sci Rep. 6:389012016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Konopke R, Distler M, Ludwig S and
Kersting S: Location of liver metastases reflects the site of the
primary colorectal carcinoma. Scand J Gastroenterol. 43:192–195.
2008. View Article : Google Scholar
|
|
32
|
Desai AG, Park CH and Schilling JF:
'Streaming' in portal vein. Its effect on the spread of metastases
to the liver. Clin Nucl Med. 10:556–559. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
König J, Cui Y, Nies AT and Keppler D:
Localization and genomic organization of a new hepatocellular
organic anion transporting polypeptide. J Biol Chem.
275:23161–23168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Evangeli L, Ioannis S, Valentinos K,
Antigony M, Elli I, Eleftheria H, Vasiliki G and Evangelos B:
SLCO1B3 screening in colorectal cancer patients using
High-Resolution Melting Analysis method and immunohistochemistry.
Tumour Biol. 39:1010428317691176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kullak-Ublick GA, Ismair MG, Stieger B,
Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ and
Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and
its functional comparison with three other OATPs of human liver.
Gastroenterology. 120:525–533. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Letschert K, Faulstich H, Keller D and
Keppler D: Molecular characterization and inhibition of amanitin
uptake into human hepatocytes. Toxicol Sci. 91:140–149. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kounnis V, Ioachim E, Svoboda M, Tzakos A,
Sainis I, Thalhammer T, Steiner G and Briasoulis E: Expression of
organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human
pancreatic cancer reveals a new class of potential therapeutic
targets. Onco Targets Ther. 4:27–32. 2011.PubMed/NCBI
|
|
38
|
Lee W, Belkhiri A, Lockhart AC, Merchant
N, Glaeser H, Harris EI, Washington MK, Brunt EM, Zaika A, Kim RB,
et al: Overexpression of OATP1B3 confers apoptotic resistance in
colon cancer. Cancer Res. 68:10315–10323. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lockhart AC, Harris E, Lafleur BJ,
Merchant NB, Washington MK, Resnick MB, Yeatman TJ and Lee W:
Organic anion transporting polypeptide 1B3 (OATP1B3) is
overexpressed in colorectal tumors and is a predictor of clinical
outcome. Clin Exp Gastroenterol. 1:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zarour LR, Anand S, Billingsley KG, Bisson
WH, Cercek A, Clarke MF, Coussens LM, Gast CE, Geltzeiler CB,
Hansen L, et al: Colorectal cancer liver metastasis: Evolving
paradigms and future directions. Cell Mol Gastroenterol Hepatol.
3:163–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brenner S, Riha J, Giessrigl B, Thalhammer
T, Grusch M, Krupitza G, Stieger B and Jäger W: The effect of
organic anion-transporting polypeptides 1B1, 1B3 and 2B1 on the
antitumor activity of flavopiridol in breast cancer cells. Int J
Oncol. 46:324–332. 2015. View Article : Google Scholar
|
